Clin2
NCT07394855Worth exploringRecruiting

Persistent fatigue after EBV infection

Fatigue Post Viral

This study looks at why fatigue doesn't go away after an EBV infection. It tests people who are early in their illness to understand the mechanisms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
16 years to 39 years
Study type
Observational

Who can take part

  • You must have a positive lab test for Epstein-Barr Virus (EBV).
  • Your first symptoms must have started between 3 and 6 weeks ago.
  • You cannot have other medical conditions (seasonal allergies or asthma without symptoms are allowed).
  • You cannot be using any regular medications (birth control or occasional pain relievers are okay).
  • You cannot have a major stressful life event causing fatigue, a disability that affects daily living, regular smoking, illicit drug use, or be pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06786832Recruiting
Trial for fatigued patients in primary care

This trial studies severe fatigue that started at a specific time and is not due to another illness. It aims to find better ways to diagnose, treat, and support people with long-term fatigue in primary care.

Stockholm, Gustavsberg
NCT05890599Recruiting
Yoga or health education for ongoing fatigue after COVID

This trial studies whether a yoga program (compared with health education) can reduce persistent tiredness after COVID-19. It may help if your fatigue has lasted at least 12 weeks and you think it started with COVID.

Stuttgart
NCT04308278Recruiting· Phase 4
Test two supplements for long fatigue from EBV infection

This trial studies whether two products (2LEBV® and 2LXFS®) can improve ongoing fatigue in people who have evidence of an Epstein-Barr virus (EBV) infection. It aims to see if treatment helps reduce multiple related symptoms over follow-up.

Aartselaar
NCT05127980Recruiting
Study of immune antibodies after first-time EBV infection

This study looks at how the immune system’s antibodies behave after a first-time EBV infection, including whether they mistakenly react with the body’s own tissues. You might be offered a chance to help doctors understand why some people get longer or more intense symptoms from infectious mononucleosis.

Basel
NCT03491605Recruiting
Follow-up study for people with high EBV virus levels

This study tracks health outcomes over time in people who have a high level of the EBV virus in their blood. It may help researchers understand what happens in chronic (long-lasting) EBV infection and which outcomes to watch for.

Wuhan, Hubei
NCT06775262Recruiting
chronic fatigue in internal medicine patients

This study looks at people with chronic fatigue who saw a doctor but no physical cause was found. It aims to understand their experiences better.

Almere Stad, Flevoland

Hear when a new Fatigue Post Viral trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.